10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO, CA
Other Events
Reports Second Quarter 2026 Business Updates and Financial Results
Charles S. Fuchs Appointed President, Research & Development at Erasca, Inc.
Announces Pricing of Upsized Public Offering of Common Stock
Erasca, Inc. Annual Meeting Results; Three Directors Elected
Reports First Quarter 2026 Business Updates and Financial Results
Annual Report to Security Holders
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload